Access
To read this story in full you will need to login or make a payment (see right).
News Feature
Nature 434, 557-558 (31 March 2005) | doi:10.1038/434557a; Published online 30 March 2005
Open Innovation Challenges
- More Challenges
- Powered by:
nature jobs
Business Devlopment Officer
- Rhydburg Pharmaceuticals
- Selaqui-Dehradun India
Faculty Positions
- University of Texas Medical Branch
- Galveston, TX United States
Drug safety special: Chasing shadows
Simon Frantz1
- Simon Frantz is news editor for Nature Reviews Drug Discovery.
Top of page
Abstract
Why do current safety systems sometimes fail to notice that approved drugs are causing serious adverse effects? And can surveillance methods be improved? Simon Frantz investigates.
It's 3 a.m.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
